Earnings Call · Q2 FY2024·2024-08-11

Q2 24EPS n/a·Rev n/aQ1 24EPS n/a·Rev n/aQ4 23EPS n/a·Rev n/aQ3 23EPS n/a·Rev n/a⚠ consensus missing

CUMBERLAND PHARMACEUTICALS INC CPIX

Molly Aggas — Account Supervisor

A.J. Kazimi — Chief Executive Officer

Todd Anthony — Sales Division Leader

John Hamm — Chief Financial Officer

−1.3%1d on move date−0.7% vs SPY3d−4.8%5d−8.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CPIX calls or request research access.

More CPIX calls Browse calls Request research access